MARKET

SAVA

SAVA

Cassava Sciences
NASDAQ
25.25
-1.13
-4.28%
Opening 15:35 11/13 EST
OPEN
26.31
PREV CLOSE
26.38
HIGH
27.00
LOW
25.00
VOLUME
952.29K
TURNOVER
--
52 WEEK HIGH
42.20
52 WEEK LOW
8.79
MARKET CAP
1.21B
P/E (TTM)
-66.9406
1D
5D
1M
3M
1Y
5Y
1D
What Makes Cassava Sciences (SAVA) a New Buy Stock
NASDAQ · 1d ago
A High-potential Bull Put Strategy on Cassava Sciences
Barchart · 1d ago
Anavex, Cassava Sciences, Panax Ginseng, And The Long-Term Treatment Of Alzheimer's Disease
Seeking Alpha · 2d ago
Weekly Report: what happened at SAVA last week (1104-1108)?
Weekly Report · 2d ago
Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla?
Benzinga · 5d ago
Cassava Sciences Price Target Maintained With a $116.00/Share by HC Wainwright & Co.
Dow Jones · 5d ago
HC Wainwright & Co. Reiterates Buy on Cassava Sciences, Maintains $116 Price Target
Benzinga · 5d ago
Cassava Sciences’ Simufilam Shows Promise as Disease-Modifying Alzheimer’s Treatment Amid Positive Phase 3 Trial Expectations
TipRanks · 5d ago
More
About SAVA
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. It is conducting two randomized placebo-controlled Phase III clinical trials of oral simufilam in patients with Alzheimer’s disease dementia. SavaDx, its lead investigational diagnostic product candidate, is a way to detect the presence of Alzheimer’s disease from a small sample of blood. SavaDx is a research-use only, non-safety related exploratory biomarker.

Webull offers Cassava Sciences Inc stock information, including NASDAQ: SAVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SAVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SAVA stock methods without spending real money on the virtual paper trading platform.